Antibody SACK-1 that binds CD44 glycoforms

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S388220, C435S343000, C435S334000

Reexamination Certificate

active

07816500

ABSTRACT:
Methods and compositions for modifying glycans (e.g., glycans expressed on the surface of live cells or cell particles) are provided herein.

REFERENCES:
patent: 5652343 (1997-07-01), Lasky et al.
patent: 5849898 (1998-12-01), Seed et al.
patent: 5942417 (1999-08-01), Ni et al.
patent: 6124267 (2000-09-01), McEver et al.
patent: 7332334 (2008-02-01), Xia et al.
patent: 2003/0040607 (2003-02-01), Sackstein
patent: 2006/0228340 (2006-10-01), Xia et al.
patent: WO 92/01049 (1992-01-01), None
patent: WO 96/11012 (1996-04-01), None
Berg et al. (1991), “The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1”, J. Exp. Med., 174:1461-1466.
Borges et al. (1997), “The Binding of T Cell-expressed P-selectin Glycoprotein Ligand-1 to E- and P-selectin Is Differentially Regulated”, J. Biol. Chem., 272(45):28786-28792.
Candal et al. (1996), “BMEC-1: A Human Bone Marrow Microvascular endothelial Cell Line with Primary Cell Characteristics”, Microvasc. Research, 52:221-234.
DeLuca et al. (1995), “A Novel Cobra Venom Metalloproteinase, Mocarhagin, Cleaves a 10-Amino Acid Peptide from the Mature N Terminus of P-selectin Glycoprotein Ligand Receptor, PSGL-1, and Abolishes P-selectin Binding”, J. Biologial Chem. 270(45):26734-26737.
Dimitroff et al. (2000), “A distinct glycoforrn of CD44 is an L-selectin ligand on human hematopoietic cells”, PNAS, 95(25):13841-13846.
Dimitroff et al. (2001), “Differential L-Selectin Binding Activities of Human Hematopoietic Cell L-Selectin Ligands, HCELL and PSGL-1”, J. Biol. Chem. 276(50):47623-47631.
Dimitroff et al. (2001), “CD44 Is a Major E-Selectin Ligand on Human Hematopoietic Progenitor Cells”, J. of Cell Biol., 153:1277-1286.
Doughterty et al. (1991), “Molecular Cloning of CD44R1 and CD44R2, Two Novel Isoforms of the Human CD44 Lymphocyte ‘Homing’ Receptor Expressed by Hemopoietic Cells”, J. Exp. Med., 174:1-5.
Finger et al. (1996), “Adhesion through L-selectin requires a threshold hydrodynamic shear,”, Nature, 379:266-269.
Fuhlbrigge et al. (1994), “Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells”, Nature, 389:978-981.
Girard et al. (1995), “High endothelial venules (HEVs): specialized endothelium for lymphocyte migration”, Immunol. Today, 16(9):449-457.
Goebeler et al. (1996), “Migration of highly aggressive melanoma cells or hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors”, J. Cell Science, 109:1957-1964.
Goelz et al. (1994), “Differential Expression of an E-selectin Ligand (Slex) by Two Chinese Hamster Ovary Cell Lines Transfected with the Same a(1,3)-Fucosyltransferase Gene (ELFT)”, J. Biol. Chem., 269(2):1033-1040.
Greenberg et al. (2000), “Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development”, Blood, 95(2):478-486.
Guyer et al. (1996), “P-Selectin Glycoprotein Ligand-1 (PSGL-1) Is a Ligand for L-Selectin in Neutrophil Aggregation”, Blood, 88(7):2415-2421.
Hale et al. (1992), “Bromelain Treatment of Human T Cells Removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 Surface Molecules and Markedly Enhances CD2- Mediated T Cell Activation”, J. Immunol., 149(12):3809-3816.
Jalkanen et al. (1986), “A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man”, Eur. J. Immunol., 16:1195-1202.
Jalkanen et al. (1988), “Biochemical Properties of Glycoproteins Involved in Lymphocyte Recognition of High Endothelial Venules in Man”, J. Immunol., 141(5):1615-1623.
Jutila et al. (1994), “Cell surface P- and E-selectin support shear-dependent rolling of bovine gamma/delta T cells”, J. of Immunol.,153:3917-3928.
Katoh et al. (1995), “Glycosylation of CD44 negatively regulates its recognition of hyaluronan,”, J. Exp. Med., 182(2):419-429.
Katoh et al. (1999), “Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes”, J. Immunol., 162:5058-5061.
Kugleman et al. (1992), “The Core Protein of Epican, a Heparan Sulfate Proteoglycan on Keratinocytes, Is an Alternative Form of CD44”, The Society for Investigative Dermatology, Inc., pp. 887-891.
Lawrence et al. (1987), “Effect of Flow on Polymorphonuclear Leukocyte/Endothelial Cell Adhesion”, Blood, 70(5):1284-1290.
Lawrence et al. (1999), “Threshold Levels of Fluid Shear Promote Leukocyte Adhesion through Selectins (CD62L,P,E)”, J. Cell Biol., 136(3):717-727.
Maiti et al. (1998), “TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation”, Science, 282:941-943.
Ngo et al. (1994), “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox”, The Protein Folding Problem and Tertiary Structure Prediction, pp. 433, 492-495.
Oxley et al. (1994), “Detection of an L-Selectin Ligand on a Hematopoietic Progenitor Cell Line”, Blood, 84(10):3299-3306.
Picker et al. (1990), “A unique phenotype of skin-associated lymphocyte in humans”, Am. J. Pathology, 136:1053-1068.
Ramos et al. (1998), “Functional Characterization of L-Selectin Ligands on Human Neutrophils and Leukemia Cell Lines: Evidence for Mucinlike Ligand Activity Distinct From P-Selectin Glycoprotein Ligand-1”, Blood, 91(3):1067-1075.
Sackstein (2004), J Invest Dermatol, 122:1061-1069.
Sackstein and Demitroff (2000), “A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity”, Blood, 96(8):2765-2774.
Sackstein et al. (1997), “Hematopoietic Cell L-Selectin Ligand Exhibits Sulfate-Independent Binding Activity”, Blood, 89(8):2773-2781.
Sako et al. (1993), “Expression cloning of a functional glycoprotein ligand for P-selectin”, Cell, 75(6): 1179-1186.
Sasaki et al. (1993), “Expression Cloning of a Novel Galfl(1-3/1-4)G1cNAc a2,3-Sialyltransferase Using Lectin Resistance Selection”, J. Biol. Chem., 268(30):22782-22787.
Skolnick et al. (2000), “From genes to protein structure and function: novel applications of computational approaches in the genomic era”, Trends in Biotechnology, 18:34-39.
Snapp et al. (1998), “A Novel P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Recognizes an Epitope Within the Tyrosine Sulfate Motif of Human PSGL-1 and Blocks Recognition of Both P-and L-Selectin”, Blood, 91(1):154-164.
Spertini et al. (1996), “P-Selectin Glycoprotein Ligand 1 Is a Ligand for L-Selectin on Neutrophils, Monocytes, and CD34+ Hematopoietic Progenitor Cells”, J. Cell Biol. 135(2):523-531.
Stamenkovic et al. (1991), “The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells”, EMBO Journal, 10(2):343-348.
Tu et al. (1996), “L-Selectin Binds to P-Selectin Glycoprotein Ligand-1 on Leukocytes: Interactions Between the Lectin, Epidermal Growth Factor, and Consensus Repeat Domains of the Selectins Determine Ligand Binding Specificity”, J. Immunol., 157(9):3995-4004.
Vachino et al. (1995), “P-selectin Glycoprotein Ligand-1 Is the Major Counter-receptor for P-selectin on Stimulated T Cells and Is Widely Distributed in Non-functional Form on Many Lymphocytic Cells”, J. Biol. Chem. 270(37):21966-21974.
Walcheck et al. (1993), “Bovine gamma/delta T cells bind E-selectin via a novel glycoprotein receptor: first characterization of a lymphocyte/E-selectin interaction in an animal model”, J. Exp. Med., 178(3):853-863.
Zollner et al. (1996), “The E-selectin Ligand-1 Is Selecti

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibody SACK-1 that binds CD44 glycoforms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody SACK-1 that binds CD44 glycoforms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody SACK-1 that binds CD44 glycoforms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4220569

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.